Andrew Schiermeier - Net Worth and Insider Trading

Andrew Schiermeier Net Worth

The estimated net worth of Andrew Schiermeier is at least $278,655 dollars as of 2024-11-10. Andrew Schiermeier is the EVP, COO of Intellia Therapeutics Inc and owns about 16,656 shares of Intellia Therapeutics Inc (NTLA) stock worth over $278,655. Details can be seen in Andrew Schiermeier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Schiermeier has not made any transactions after 2021-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew Schiermeier

To

Andrew Schiermeier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Schiermeier owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .

Click here to see the complete history of Andrew Schiermeier’s form 4 insider trades.

Insider Ownership Summary of Andrew Schiermeier

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2021-01-05 EVP & Chief Operating Officer

Andrew Schiermeier Latest Holdings Summary

Andrew Schiermeier currently owns a total of 1 stock. Andrew Schiermeier owns 16,656 shares of Intellia Therapeutics Inc (NTLA) as of January 5, 2021, with a value of $278,655.

Latest Holdings of Andrew Schiermeier

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2021-01-05 16,656 16.73 278,655

Holding Weightings of Andrew Schiermeier


Andrew Schiermeier Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Schiermeier has made a total of 1 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 1,377 shares on January 5, 2021, which brought Andrew Schiermeier around $76,919.

Insider Trading History of Andrew Schiermeier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Schiermeier Trading Performance

GuruFocus tracks the stock performance after each of Andrew Schiermeier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Schiermeier is -8.24%. GuruFocus also compares Andrew Schiermeier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Schiermeier within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew Schiermeier's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew Schiermeier

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.09 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew Schiermeier Ownership Network

Ownership Network List of Andrew Schiermeier

No Data

Ownership Network Relation of Andrew Schiermeier

Insider Network Chart

Andrew Schiermeier Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Andrew Schiermeier is the EVP & Chief Operating Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Andrew Schiermeier made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .

In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 62,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 62,207 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Andrew Schiermeier Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Schiermeier. You might contact Andrew Schiermeier via mailing address: C/o Intellia Therapeutics, Inc, 40 Erie Street Ste 130, Cambridge Ma 02139.